The researchers found that colonoscopy screening IBD patients within the previous three years reduced the odds of colorectal cancer development by 35 percent. Screening also reduced the risk of death if cancer does develop by 50 percent.
The results of the study serve to support previously unsupported guidelines on colonoscopy surveillance in IBD.
More articles on gastroenterology:
Does capnography add benefit to colonoscopy?
Improving access to specialty care in GI: 7 things to know
5 gastroenterologists making the news
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.